Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-073122·Gates Frontier, LLC
Schedule 13G ownership disclosure
Lyell Immunopharma Inc
Common Stock, $0.0001 par value per share · CUSIP: 55083R203
Event date: 2025-07-25
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Gates Frontier, LLC
Shares: 1,040,964.00 · Class: 5.6%
- William H. Gates III
Shares: 1,040,964.00 · Class: 5.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-073122
- Form type
- SCHEDULE 13G
- Filer
- Gates Frontier, LLC
- CIK
- CIK 1580115
- Filed
- Aug 01, 2025
- Reporting period
- Jul 25, 2025
- Description
- Schedule 13G beneficial ownership